LingZhi oligopeptides amino acid sequence analysis and anticancer potency evaluation
Author:
Affiliation:
1. The Third Affiliated Hospital of Shenzhen University
2. Shenzhen University
3. Shenzhen 518020
4. China
5. School of Medicine
6. Shenzhen 518060
7. Longgang ENT Hospital & Shenzhen ENT Institute
8. Shenzhen 518172
9. Department of Pharmacy
Abstract
The LingZhi (Ganoderma lucidum) has been used as a therapeutic agent for decades, but the antitumor potency of LingZhi oligopeptides (LZOs) was not well explored. In current study, ten novel LZOs were amino acid sequence identified and anticancer potency evaluated.
Publisher
Royal Society of Chemistry (RSC)
Subject
General Chemical Engineering,General Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2020/RA/C9RA10400C
Reference27 articles.
1. Risk stratification based on screening history: the NELSON lung cancer screening study
2. Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors
3. Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer
4. The relationship between dosimetric factors, side effects, and survival in patients with non–small cell lung cancer treated with definitive radiotherapy
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. UPLC-ESI-MS/MS-based widely targeted metabolomics reveals differences in metabolite composition among four Ganoderma species;Frontiers in Nutrition;2024-03-18
2. The Research Progress of Bioactive Peptides Derived from Traditional Natural Products in China;Molecules;2023-09-03
3. A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer;Chinese Medicine;2023-08-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3